Elevance Health, Inc. (NYSE:ELV - Get Free Report) EVP Felicia F. Norwood sold 14,111 shares of the stock in a transaction that occurred on Tuesday, April 23rd. The stock was sold at an average price of $533.74, for a total value of $7,531,605.14. Following the completion of the transaction, the executive vice president now owns 31,460 shares in the company, valued at approximately $16,791,460.40. The sale was disclosed in a filing with the Securities & Exchange Commission, which is accessible through this link.
Elevance Health Stock Performance
Shares of Elevance Health stock opened at $539.70 on Friday. The company has a market cap of $125.44 billion, a PE ratio of 20.40, a price-to-earnings-growth ratio of 1.18 and a beta of 0.78. Elevance Health, Inc. has a 52 week low of $412.00 and a 52 week high of $542.07. The business has a 50 day moving average price of $511.40 and a 200-day moving average price of $485.81. The company has a quick ratio of 1.37, a current ratio of 1.37 and a debt-to-equity ratio of 0.54.
Elevance Health (NYSE:ELV - Get Free Report) last issued its quarterly earnings results on Thursday, April 18th. The company reported $10.64 EPS for the quarter, beating analysts' consensus estimates of $10.54 by $0.10. Elevance Health had a return on equity of 20.62% and a net margin of 3.64%. The company had revenue of $42.27 billion during the quarter, compared to the consensus estimate of $42.49 billion. During the same period last year, the business posted $9.46 earnings per share. Elevance Health's revenue was up .9% on a year-over-year basis. Equities analysts anticipate that Elevance Health, Inc. will post 37.25 earnings per share for the current fiscal year.
Elevance Health Dividend Announcement
Don’t Miss Out on the AI Gold Rush That’s Just Getting Started
From Banyan Hill Publishing | Ad
“Titan of Tech” Bets Big on Tiny AI Company
He’s made as much as 3,250,000% in just three years on companies like Facebook, Airbnb, and PayPal…
But our research shows his latest investment could be his most successful venture yet.
See how you can invest alongside him
The firm also recently announced a quarterly dividend, which will be paid on Tuesday, June 25th. Stockholders of record on Monday, June 10th will be paid a dividend of $1.63 per share. This represents a $6.52 dividend on an annualized basis and a dividend yield of 1.21%. The ex-dividend date is Monday, June 10th. Elevance Health's payout ratio is 24.64%.
Analyst Upgrades and Downgrades
Several research analysts have issued reports on ELV shares. Royal Bank of Canada increased their price target on Elevance Health from $574.00 to $575.00 and gave the stock an "outperform" rating in a report on Friday, April 19th. UBS Group increased their price target on Elevance Health from $585.00 to $605.00 and gave the stock a "buy" rating in a report on Friday, April 19th. Wells Fargo & Company increased their price target on Elevance Health from $557.00 to $600.00 and gave the stock an "overweight" rating in a report on Friday, April 19th. Truist Financial reiterated a "buy" rating and issued a $600.00 price target (up previously from $580.00) on shares of Elevance Health in a report on Friday, April 19th. Finally, Jefferies Financial Group increased their price target on Elevance Health from $602.00 to $604.00 and gave the stock a "buy" rating in a report on Friday, April 19th. One analyst has rated the stock with a hold rating and thirteen have given a buy rating to the stock. According to MarketBeat, the company presently has an average rating of "Moderate Buy" and a consensus target price of $587.42.
Read Our Latest Report on ELV
Institutional Investors Weigh In On Elevance Health
A number of hedge funds have recently made changes to their positions in ELV. Norges Bank bought a new stake in shares of Elevance Health during the 4th quarter worth $1,347,434,000. Massachusetts Financial Services Co. MA bought a new stake in shares of Elevance Health during the 4th quarter worth $467,141,000. Canoe Financial LP raised its stake in shares of Elevance Health by 158.1% during the 4th quarter. Canoe Financial LP now owns 844,122 shares of the company's stock worth $398,054,000 after purchasing an additional 517,116 shares during the period. Morningstar Investment Services LLC bought a new stake in shares of Elevance Health during the 4th quarter worth $239,244,000. Finally, Focused Investors Fund L P bought a new stake in shares of Elevance Health during the 1st quarter worth $249,884,000. 89.24% of the stock is currently owned by institutional investors.
About Elevance Health
(
Get Free Report)
Elevance Health, Inc, together with its subsidiaries, operates as a health benefits company in the United States. The company operates through four segments: Health Benefits, CarelonRx, Carelon Services, and Corporate & Other. It offers a variety of health plans and services to program members; health products; an array of fee-based administrative managed care services; and specialty and other insurance products and services, such as stop loss, dental, vision, life, disability, and supplemental health insurance benefits.
Read More
This instant news alert was generated by narrative science technology and financial data from InsiderTrades.com in order to provide readers with the fastest and most accurate reporting. This story was reviewed by InsiderTrades.com's editorial team prior to publication. Please send any questions or comments about this story to [email protected].
